Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.20 EUR
56.66 M EUR
361.14 M EUR
37.89 M
About Shanghai Haohai Biological Technology Co., Ltd. Class A
Sector
Industry
CEO
Jian Ying Wu
Website
Headquarters
Shanghai
Founded
2007
ISIN
CNE100001W69
FIGI
BBG008LYF016
Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, production and sales of medical devices and pharmaceuticals. It offers orthopedics, medical aesthetics, wound healing, hemostasis, ophthalmology and anti-adhesion products. The company mainly offers intraocular lens (IOL), ophthalmology and optometry end products, medical sodium hyaluronate, medical chitosan, medical collage sponge, rhEGF amd other related products. Shanghai Haohai Biological Technology was founded on January 24, 2007 and is headquartered in Shanghai, China.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange Shanghai Haohai Biological Technology Co., Ltd. Class H stocks are traded under the ticker 5HB.
Yes, you can track Shanghai Haohai Biological Technology Co., Ltd. Class H financials in yearly and quarterly reports right on TradingView.
Shanghai Haohai Biological Technology Co., Ltd. Class H is going to release the next earnings report on Oct 24, 2025. Keep track of upcoming events with our Earnings Calendar.
5HB net income for the last quarter is 14.09 M EUR, while the quarter before that showed 11.47 M EUR of net income which accounts for 22.83% change. Track more Shanghai Haohai Biological Technology Co., Ltd. Class H financial stats to get the full picture.
Shanghai Haohai Biological Technology Co., Ltd. Class H dividend yield was 4.10% in 2024, and payout ratio reached 55.93%. The year before the numbers were 2.73% and 40.73% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 5, 2025, the company has 2.16 K employees. See our rating of the largest employees — is Shanghai Haohai Biological Technology Co., Ltd. Class H on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Shanghai Haohai Biological Technology Co., Ltd. Class H EBITDA is 64.17 M EUR, and current EBITDA margin is 22.74%. See more stats in Shanghai Haohai Biological Technology Co., Ltd. Class H financial statements.
Like other stocks, 5HB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Shanghai Haohai Biological Technology Co., Ltd. Class H stock right from TradingView charts — choose your broker and connect to your account.